news aktuell GmbH

The high-performance single-seater 777 hypercar is born in Monza

22.11.2022 11:05:00 CET | news aktuell GmbH | Press release

Share
777 Hypercar prototype/Credits 777 Hypercar
777 Hypercar prototype/Credits 777 Hypercar

(Monza, Italy): – The 777 hypercar is a new Italian hypercar born of the excellent partnership with Andrea Levy, Dallara, and Gibson, built from technology used in motorsports and all informations and images are on www.777hypercar.com.

777 hypercar is built by 777 Motors, the car manufacturer based in the Autodromo Nazionale Monza and founded by Andrea Levy, an entrepreneur, car collector, racing driver, and president of MIMO Milano Monza Motorshow. The 777 hypercar project will be presented on November 22, limited to just 7 units, each of which will cost 7 million euros.

777 hypercar is at the top for performance thanks to an FIA-homologated carbon monocoque developed by Dallara, which generate an incredible downforce of 2,100 kg at a speed of 370 km/h, an extremely low weight of 900 kg, and a lateral acceleration from 3.5 to 4 g that keeps the car glued to the asphalt, giving an incredible estimate lap time of just 1 minute and 33 seconds in the Monza Circuit. The engine is a naturally aspirated V8, 4,500 cc of displacement, which develops 730 hp at 9,000 rpm, powered by synthetic fuels.

Along with the 777 hypercar, owners will also receive custom attire and machinery, tailored to their liking. An advanced machine is created for ad hoc to reinforce the neck area.

Data sheet 777 hypercar engineered by Dallara:

Headquarters: Autodromo Nazionale di Monza, the Temple of Speed

Chassis: FIA-homologated carbon monocoque

Engine: 8 V-cylinders

Displacement: 4,500 cc

Power: 730 hp at 9,000 rpm

Top speed: 370 km / h.

Weight: 900 kg

Lateral acceleration: 3.5 / 4.0 g.

Downforce: 2,100 kg at 370 km / h

Monza lap time: 1m33s

Limited edition of seven units

Price: 7 million euros

Delivery: from 2025

Contacts

Images

777 Hypercar prototype/Credits 777 Hypercar
777 Hypercar prototype/Credits 777 Hypercar
Download

About news aktuell GmbH

news aktuell GmbH
news aktuell GmbH
Mittelweg 144
20148 Hamburg

+49 (0)40 4113-32589http://www.newsaktuell.de

news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

Slovak outlet Denník N republishes numerous false allegations about Alisher Usmanov that courts have already held to be unlawful13.3.2026 08:48:33 CET | Press release

(Hamburg, Germany - 12 March 2026) On 11 March 2026, the Slovak news outlet Denník N published an article concerning the alleged efforts of the Slovak government to secure the removal of two Russian nationals from the EU sanctions list. The article contained an extensive passage concerning our client, Mr Alisher Burkhanovich Usmanov. By letter dated 12 March 2026, Denník N was requested, in order to avoid court proceedings, to provide a cease-and-desist undertaking backed by a contractual penalty. “The article was published on the eve of the European Commission’s decision on the extension of the sanctions. It reads as if its authors had taken particular care to assemble, in a single piece, every factual allegation that courts have previously found to be unlawful,” said Mr Usmanov’s lawyer, Joachim Nikolaus Steinhöfel. The article contained a dozen such statements about Alisher Usmanov, even though these very allegations have for years been prohibited, retracted, deleted or corrected in

Ship parades, evening shows and partner region Liverpool The 837th HAMBURG PORT ANNIVERSARY with a top programme11.3.2026 14:02:16 CET | Press release

(Hamburg, 11 March 2026) From 8 to 10 May 2026, Hamburg is celebrating its 837th HAMBURG PORT ANNIVERSARY. The programme includes traditional highlights such as the arrival and departure parades and the unique tugboat ballet, as well as several evening shows and the fascinating fireworks display. The programme will be supplemented by new events on the water and on land. The Big Arrival Parade on Friday, 8 May, at 1:30 p.m. marks the start of the festivities and is always an unforgettable experience: more than 100 impressive ships sail up the Elbe right before the eyes of the spectators. The majestic tall ship, the Norwegian three-masted barque Statsraad Lehmkuhl, is particularly stunning. The floating Elbe stage in front of the Landungsbrücken is THE artistic anchor of the HAMBURG PORT ANNIVERSARY: Elbe in Concert presents visitors with rousing live music and impressive performances, creating a unique atmosphere against the backdrop of the harbour skyline at night. This year’s partner

Grünenthal licenses exclusive South Korean rights to Qutenza® to BCWorld Pharm5.3.2026 08:54:06 CET | Press release

Aachen, Germany & Yeoju, South Korea, 5 March 2026 – Grünenthal, a global leader in pain management and related diseases, and BCWorld Pharm Co., Ltd. ("BCWP"), a specialty company actively expanding and diversifying its pain management portfolio through global open innovation partnerships, announced today that they have entered into a definitive agreement whereby BCWP will have the exclusive South Korean rights to Qutenza®, a topical, non-systemic, non-opioid patch treatment. In Europe, the product is indicated for the management of peripheral neuropathic pain.

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye